Publicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (25)

2024

  1. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  2. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  3. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

    Blood Advances, Vol. 8, Núm. 18, pp. 4950-4959

2023

  1. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376

  2. Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder

    International Journal of Bipolar Disorders, Vol. 11, Núm. 1

2022

  1. Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes

    World Journal of Biological Psychiatry, Vol. 23, Núm. 3, pp. 208-218

  2. Association between polarity of first episode and solar insolation in bipolar I disorder

    Journal of Psychosomatic Research, Vol. 160

  3. Education physique, conduites motrices et sémiose: pour une éducation sémiotrice

    Semiotica, Vol. 2022, Núm. 248, pp. 105-128

  4. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

  5. Introduction: semiotricity

    Semiotica

  6. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

    European Neuropsychopharmacology, Vol. 54, pp. 90-99

2021

  1. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

    European Neuropsychopharmacology, Vol. 47, pp. 54-61

  2. Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder

    Nature Communications, Vol. 12, Núm. 1

  3. Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder

    International Journal of Bipolar Disorders, Vol. 9, Núm. 1

2020

  1. Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients

    Hormone Research in Paediatrics, Vol. 93, Núm. 3, pp. 182-196

  2. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

    European Neuropsychopharmacology, Vol. 36, pp. 121-136

2019

  1. ACUsmart continuous renal replacement therapy platform: Multicenter pilot study for technical and clinical assessment (A.M.P. Study)

    Blood Purification, Vol. 48, Núm. 1, pp. 60-66

  2. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients with Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial

    JAMA

2018

  1. Diagnosis and management of pseudohypoparathyroidism and related disorders: First international Consensus Statement

    Nature Reviews Endocrinology, Vol. 14, Núm. 8, pp. 476-500

2017

  1. Generalizability of clinical trial results for adolescent major depressive disorder

    Pediatrics, Vol. 140, Núm. 6